Chemical Peel

Solar Lentigines can be successfully treated with a LimeLight Facial.  It is important to provide patient teaching about the formation of solar lentigines, importance of avoiding sun exposure and the use of sun block.
Laser based technology can remove the lentigines. In order to protect the patient investment it is crucial that the patient recieve adequate education related the skin care treatment to prevent the formation of additional lentigines.

Lentigo

The initial appearance of lentigines varies widely and depends on the following:

• Race
• History of exposures
• Genetic predisposition
• Other factors, depending on the type of lentigo

Solar lentigo (eg, actinic lentigo, senile lentigo, sun spot, liver spot) is the most common benign sun-induced lesion that occurs in sun-exposed areas.

• Solar lentigo most commonly appears on the face, arms, dorsa of the hands, and upper part of the trunk.
• The spots initially are smaller than 5 mm in diameter.
• The surface of the lesions is either flat or depressed, and it may be split by fine wrinkles.
• The lesions are usually brown, but the color may range from yellow-tan to black. Older lesions are often dark brown or brownish black.
• Solar lentigines slowly increase in number and in size. Many lesions eventually coalesce to form larger patches.
• Although these lesions are most common in individuals aged 30-50 years, they are now seen in younger individuals because of their increased exposure to sun tanning and the use of artificial sources of UV light.
• Although they are often called liver spots, they are not a manifestation of systemic disease

• Author: Robert A Schwartz, MD, MPH, Professor and Head of Dermatology, Professor of Medicine, Professor of Pediatrics, Professor of Pathology, Professor of Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
  Coauthor(s): Jason F Okulicz, MD, Assistant Professor of Medicine, Uniformed Services University of the Health Sciences; Fellow, Department of Infectious Disease, Wilford Hall United States Air Force Medical Center; Sergiusz Jozwiak, MD, PhD, Head, Professor, Department of Child Neurology, The Children's Memorial Health Institute of Warsaw, Poland